Paul J. Carson, MD, FACP
Professor of Practice
Master of Public Health Program
206F Research 2
Bachelor of Arts, Natural Science, 1982
St. John’s University
Doctor of Medicine, 1986
University of North Dakota School of Medicine and Health Sciences
Internal Medicine Residency, 1986-1990
University of Nebraska
Fellowship in Infectious Diseases, 1991-1993
University of Minnesota
Director of Infection Prevention and Control
Sanford Health, Fargo, ND
Board Certified in Internal Medicine and Infectious Diseases through the American Board of Internal Medicine
Areas of Expertise and Research Interests
Vaccination practice and policy
West Nile virus infection
Faculty member, Master of Public Health Program, infectious disease track
Advisor and practicum mentor, infectious disease track MPH students
Infectious Disease Society of America
Society for Healthcare Epidemiology of America
American College of Physicians
Catholic Medical Association
Awards and Honors
Fellow of the American College of Physicians
Member of the Alpha Omega Alpha medical honor society
UND Transitional Year resident’s “Outstanding Teacher of the Year” - 1997
Best Doctors in America
MPH 735 Principles of Infectious Diseases I
MPH 736 Principles of Infectious Diseases II
Guerrero D, Wagner M, Carson G, Hanish C, Thompson J, Orr M, Roth F, Carson PJ. Utility of a single nasal PCR assay in predicting absence of skin and environmental contamination of hospitalized patients with past MRSA. Accepted October 2015, American Journal of Infection Control.
Carson PJ, Danford M, Carson G, Hanish C, Thompson J, Roth F, Orr M, Traynor M, Guerrero D. Bringing Down the Flag: Streamlining the Growing Population of Patients on Contact Precautions for Prior Methicillin Resistant Staphylococcus Aureus Infection or Colonization. Infection Control and Hospital Epidemiology. February 2015, pp 1-3.
Carson PJ, Prince HE, Biggerstaff BJ, Lanciotti R, Tobler L, Busch M. Characteristics of antibody responses in West Nile virus seropositive blood donors. J Clin Micro. Oct, 2013. Epub ahead of print.
Nowak M, Nelson RN, Breidenbach J, Thompson P, Carson PJ. Clinical and economic outcomes of a prospective antimicrobial stewardship program. American J Health-Syst Pharm. Vol 69, Sep 1, 2012.
Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borchardt SM, Busch MP. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect. 2012 May 28:1-5.
Carson PJ, Borchardt SM, Custer B, et al. Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerging Infectious Diseases. Vol. 18, No. 4, April 2012
Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, Bergloff P, Crosby RD. Long-Term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis Sep 2006; Vol 43:723-730.
Carson PJ, Steidler T, Patron R, Tate JM, Tight R, Smego RA. Plasma cell pleocytosis in cerebrospinal fluid in patients with West Nile Virus encephalitis. Clin Infect Dis Jul 2003; Vol 37
Carson PJ, Nichol KL, O’Brien J, Hilo P, Janoff EN. Immune function and vaccine responses in healthy advanced elderly patients. Arch Intern Med 2000; 160(13):2017-24.
Carson PJ, Schut RL, Simpson ML, O'Brien J, Janoff EN. Antibody class subclass responses to pneumococcal polysaccharides following immunization of HIV-infected patients. J Infect Dis 1995; 172:340-5.